IFNG and macrophage activation syndrome: Since they were concomitantly affecting different proinflammatory pathways, these drugs could simultaneously target IFN-γ and other pathogenic mechanisms of MAS during AOSD, possibly allowing for better management of cytokine storm syndrome in these patients [61].